Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.

Journal of ovarian research - 27 Jan 2020

Yang Dan, He Yang, Wu Bo, Deng Yan, Wang Nan, Li Menglin, Liu Yang

Abstract excerpt

BACKGROUND: Ovarian cancer (OC) ranks fifth as a cause of gynecological cancer-associated death globally. Until now, the molecular mechanisms underlying the tumorigenesis and prognosis of OC have not been fully understood. This study aims to identify hub genes and therapeutic drugs involved in OC. METHODS: Four gene expression profiles (GSE54388, GSE69428, GSE36668, and GSE40595) were downloaded from the Gene...

Topics

Join the communities discussing this publication.

Databases, Genetic
Early Detection of Cancer
Gene Ontology
Gene Regulatory Networks
MicroRNAs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Ovarian Neoplasms

Progression-Free Survival

Protein Interaction Maps

Source

Open in PubMed Open full text

Identifiers

PMID: 31987036
DOI: 10.1186/s13048-020-0613-2
PMCID: PMC6986075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.PMID 31987036Read ↗

Identification of prognosis-related hub genes of ovarian cancer through bioinformatics analyses and experimental verificationSemantic proximity Read ↗

Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian CancerSemantic proximity Read ↗

Identification of hub genes and a prognostic model associated with ovarian cancerSemantic proximity Read ↗

Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental ValidationSemantic proximity Read ↗

Screening key genes related to ovarian cancer and exploring their possible molecular mechanismsSemantic proximity Read ↗

Identification of hub genes and a prognostic model associated with ovarian cancerSemantic proximity Read ↗

Recognition of multiple potential diagnostic biomarkers and therapeutic targets for ovarian serous cystadenocarcinoma (OSOC)Semantic proximity Read ↗

Screening and identification of key biomarkers and related transcription factors in ovarian cancer by integrated bioinformatics analysisSemantic proximity Read ↗

Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silicoSemantic proximity Read ↗

Identification and validation of a 9-gene signature for the prognosis of ovarian cancer by integrated bioinformatical analysisSemantic proximity Read ↗

In silico identification and interaction analysis of Hub Genes and miRNAs in Gynecological Cancer and their potential role as biomarkersSemantic proximity Read ↗

Comprehensive analyses reveal three-gene signatures in ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.